Roger Viney, Ph.D. has been named director of sales & marketing Europe and Asia for Hovione. Thomas Eisele, Ph.D. has been named general manager R&D at the company and Steve Beagle has been named director of sales & marketing, North America.

Dr. Viney will lead Hovione’s sales and marketing efforts outside North America and is based at Hovione headquarters in Loures, Portugal. Steve Beagle will lead those efforts for the North America territory and is based at the Hovione’s Technology Transfer Center in New Jersey. Both Dr. Viney and Mr. Beagle are responsible for the development of sales and marketing strategies in line with the strategies of Hovione’s four business units: Exclusive, Particle Design, Generics and Pharma. Dr. Eisele is responsible for corporate R&D and reports to chief executive officer Guy Villax. The R&D group includes Process Chemistry, Analytical Chemistry, Particle Design, Project Management and Pilot Plant.

“We are pleased to welcome Roger, Thomas and Steve to the Hovione team,” said Mr. Villax. “These three individuals have a distinguished track record in the industry and their extensive experience will be an invaluable resource to the company and broadens the executive management team at an important stage in the growth of our business.”

Prior to joining Hovione, Dr. Viney held various positions at Rhone-Poulenc/Rhodia from 1993 to present, most recently in Global Business Management. Prior to that he worked in senior roles in sales, marketing and technical management.

Dr. Eisele worked in Switzerland for 13 years in the area of Custom Research and Custom Manufacturing at CarboGen-Amcis, Rohner and SynphaBase. During that time Dr. Eisele held several positions in R&D, marketing and sales, global business development, shared services and general management. He began his professional career at Nycomed in the area of Medicinal Chemistry.

Mr. Beagle has a diverse 24-year history working in global roles within the pharmaceutical industry ranging from product management to sales and marketing. He is well known in the pharmaceutical manufacturing community and brings a wealth of knowledge to this position. Most recently he was at DSM where he was senior director of Business Development. Prior to this position he was at Stiefel Laboratories where he held management positions in Business Development and Technical Service. Mr. Beagle has also worked for BASF, American Cyanamid, and R.W. Greeff.